Skip to content

Learn how Flatiron is enabling diversity in clinical trials

Real-World Evidence

Search
Use Cases
Content Type
Featured
Publication summary
The association between baseline hepatic or renal function and clinical outcomes for patients with NSCLC treated with a PD-1/PD-L1 blocking antibody using real-world and trials data
Clinical Pharmacology & Therapeutics
Liu Q, Mathur R, Xu Y, Torres AZ, Miksad RA, Liu C, Smithson H, Wang Y, Hao Zhu, Booth B, Huang S, Zhi J, Sridhara R, Blumenthal GM, Larkins E, Mishra-Kalyani PS, Rivera DR, Kluetz PG, Sharon E
May 2023
Video
Beyond synthetic controls: Near-term opportunities for regulatory RWE
October 2021